CompletedN/AMDMA

The NeXT Study; The Netherlands XTC Toxicity Study

Sponsored by UMC Utrecht

NCT ID
NCT00235768
Target Enrollment
225 participants
Start Date
2002-04
Est. Completion
2005-07

About This Study

The purpose of this study is to investigate the possible neurotoxic effects of the party-drug Ecstasy (MDMA)on brain and brain function in humans. Main research questions concern the causality, course and clinical relevance of the neurotoxicity of ecstasy

Conditions Studied

Ecstasy (Drug)N-Methyl-3,4-MethylenedioxymethamphetaminePsychopathology

Eligibility

Age:18 Years - 35 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* between 18 - 35 years of age

Exclusion Criteria:

* severe medical or neuropsychiatric illness
* use of prescribed psychotropic medications such as SSRI's
* use of intravenous drugs
* pregnancy
* contra-indications for MRI investigation

Study Locations (3)

Bonger Institute of Criminology
Amsterdam, North Holland, Netherlands
Academic Medical Center Amsterdam
Amsterdam, North Holland, Netherlands
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

The NeXT Study; The Netherlands XTC Toxicity Study | Huxley